Etripamil
MSP-2017-1138
Phase 3 small_molecule terminated
Quick answer
Etripamil for Paroxysmal Supraventricular Tachycardia is a Phase 3 program (small_molecule) at Milestone Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Milestone Pharmaceuticals
- Indication
- Paroxysmal Supraventricular Tachycardia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated